Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and Activity of Novel Oxadiazole Based Compounds That Target Poly(ADP-ribose) Polymerase
Divakar Vishwanath, Swamy Savvemala Girimanchanaika, Dukanya Dukanya, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 703-703
Open Access | Times Cited: 10

Showing 10 citing articles:

Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116535-116535
Closed Access | Times Cited: 6
Selective PARP1 inhibitors, PARP1-based dual-target inhibitors, PROTAC PARP1 degraders, and prodrugs of PARP1 inhibitors for cancer therapy
Xiaopeng Peng, Wanyi Pan, Feng Jiang, et al.
Pharmacological Research (2022) Vol. 186, pp. 106529-106529
Closed Access | Times Cited: 21
Development of 1-(4-(Substituted)piperazin-1-yl)-2-((2-((4-methoxybenzyl)thio)pyrimidin-4-yl)oxy)ethanones That Target Poly (ADP-Ribose) Polymerase in Human Breast Cancer Cells
Suresha N. Deveshegowda, Prashant K. Metri, Rashmi Shivakumar, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2848-2848
Open Access | Times Cited: 12
Discovery of oxazine-linked pyrimidine as an inhibitor of breast cancer growth and metastasis by abrogating NF-κB activation
Jie Yuan, Bhanuprakash C. Narasimhachar, Akshay Ravish, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Recent advances in structural types and medicinal chemistry of PARP-1 inhibitors
Ling Yu, Zhiwei Yan, Youde Wang, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 8, pp. 1265-1276
Closed Access | Times Cited: 10
Background-Quenched Aggregation-Induced Emission through Electrostatic Interactions for the Detection of Poly(ADP-ribose) Polymerase-1 Activity
Fengli Gao, Ruimin Zhao, Liping Huang, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4759-4759
Open Access | Times Cited: 3
Development of an Environment-Friendly and Electrochemical Method for the Synthesis of an Oxadiazole Drug-Scaffold That Targets Poly(ADP-Ribose)Polymerase in Human Breast Cancer Cells
Sindhu M. Parameshwaraiah, Xi Zhang, Akshay Ravish, et al.
Catalysts (2023) Vol. 13, Iss. 8, pp. 1185-1185
Open Access | Times Cited: 2
Design, Synthesis, in Vitro, and in Silico Evaluations of 1,3,4‐Oxadiazole Derivatives Linked to the Pyrrolo[2,3‐d]pyrimidine Moieties as Potent Antimicrobial Targets
Jeevan Lal Patel, Naveen Kumar Sureddy, Murali Boddupalli, et al.
ChemistrySelect (2024) Vol. 9, Iss. 23
Closed Access
A Theoretical Study of the Interaction of PARP-1 with Natural and Synthetic Inhibitors: Advances in the Therapy of Triple-Negative Breast Cancer
Albert Gabriel Turpo-Peqqueña, Emily Katherine Leiva-Flores, Sebastián Luna-Prado, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 9, pp. 9415-9429
Open Access
Electrochemical Synthesis of Versatile Pyrimidine and Oxadiazoles Tethered Triazoles as Inhibitors of VEGFR-2 in Human Breast Cancer Cells
Akshay Ravish, Tejaswini P. Siddappa, Xi Zhang, et al.
Catalysts (2023) Vol. 13, Iss. 10, pp. 1353-1353
Open Access | Times Cited: 1
Page 1

Scroll to top